<?xml version="1.0" encoding="UTF-8"?>
<p id="Par31">Another activity that could be on the critical path is viral clearance studies. Platform process steps with a sufficient performance database would enable modular claims of viral clearance without the need to conduct product-specific studies
 <sup>
  <xref ref-type="bibr" rid="CR21">21</xref>
 </sup>. These apply to steps such as low-pH inactivation, virus filtration and chromatography.
</p>
